RxDoctor Payments Data

Tamer Amer, DO

Advanced Heart Failure and Transplant Cardiology · San Antonio, TXNPI 1417342296

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,925 of the $10,923 with a category attached, or 81.7%. 28 manufacturers reported payments, led by Abbott at 58.2% of the total. Reporting peaked in 2023 at $4,258 and has fallen 84.2% since, to $674 in 2025. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in TX, where the typical reported total is $11,093.

$10,923in general payments, 2019–2025

Across 273 payments — averaging $40.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$6K
  • AstraZeneca$554
  • Actelion Pharmaceuticals US, Inc.$529
  • Cardiovascular Systems Inc.$429
  • Inari Medical, Inc.$366
  • Impulse Dynamics (USA) Inc.$366
  • plus $2K from 22 others
$149in research payments, 2019–2025

Across 1 payment — averaging $149.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abiomed$149

What the payments were for

  • Travel & lodging$1,90917%
  • Food & beverage$8,92582%
  • Education$901%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,923 in reported general payments places this provider in the 45th percentile of 75 advanced heart failure and transplant cardiology providers in Texas.

See all advanced heart failure and transplant cardiology providers in Texas

Medicare billing

Part B allowed, 2024
$110,137
Medicare patients
269
Services billed
1,036

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other advanced heart failure and transplant cardiology in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →